SCHEMBL24495154

SCHEMBL24495154

C(CN1CCC(c2ccccc2)CC1)=C(c1ccccc1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.64
CHRNB4 P30926 1/20 0.64
CHRNA3 P32297 1/20 0.64
CHRNA4 P43681 1/20 0.64
SLC18A3 Q16572 4/20 0.55
SIGMAR1 Q99720 5/20 0.55
DRD2 P14416 1/20 0.51
CARM1 Q86X55 1/20 0.51
PRMT6 Q96LA8 1/20 0.51
KMT2A Q03164 3/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
MEN1 O00255 2/20 0.48
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13503963 0.83 SIGMAR1 (0.73) CHRNB2CHRNB4CHRNA3CHRNA4SIGMAR1
SCHEMBL13503780 0.79 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA4SIGMAR1
SCHEMBL28351310 0.77 SLC18A3 (0.57) SLC18A3SIGMAR1DRD2CARM1PRMT6
SCHEMBL175904 0.77 SLC18A3 (0.57) SLC18A3SIGMAR1DRD2CARM1PRMT6
SCHEMBL13504094 0.76 CHRNB2 (0.70) CHRNB2CHRNB4CHRNA3CHRNA4SIGMAR1
SCHEMBL4356995 0.76 CHRNB2 (0.70) CHRNB2CHRNB4CHRNA3CHRNA4SIGMAR1
SCHEMBL8967407 0.74 SLC18A3 (0.73) SLC18A3SIGMAR1DRD2CARM1PRMT6
SCHEMBL22485473 0.74 DRD2 (0.58) SLC18A3SIGMAR1DRD2CARM1PRMT6
SCHEMBL22468789 0.74 DRD2 (0.58) SLC18A3SIGMAR1DRD2CARM1PRMT6
SCHEMBL22468791 0.74 DRD2 (0.58) SLC18A3SIGMAR1DRD2CARM1PRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043602-B2 Fendiline derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-07-23 US disclosed
US-12043602-B2 Fendiline derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-07-23 US disclosed
US-20220177440-A1 Fendiline Derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2022-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043602-B2 Fendiline derivatives CYP11B2, CYP3A7, CYP4F2 CHRNB2 300/4885CHRNB4 430/4885CHRNA3 451/4885
US-20220177440-A1 Fendiline Derivatives CYP11B2, CYP3A7, CYP4F2 CHRNB2 300/4885CHRNB4 430/4885CHRNA3 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.